Manager,FP&A,Europe

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Manager, FP&A Europe will support the Sr Director FP&A Europe in driving financial planning, reporting, business analytics, and operational execution across the European region as the company prepares for commercial growth. Based in Basel, Switzerland, this role will coordinate budgeting and forecasting activities, deliver financial insights, support reporting and planning tools, and help ensure efficient day-to-day finance operations across European affiliates and functions. The ideal candidate is analytical, hands-on, highly organized, and comfortable operating in a fast-paced biotech environment. Support FP&A & Financial Operations Support annual budget, quarterly forecast, and long-range planning processes across Europe. Coordinate planning timelines, templates, and data collection with regional stakeholders. Assist in maintaining European management P&L structures by country, function, and product. Prepare monthly Actuals vs. Budget / Forecast reporting and variance analyses. Consolidate and validate financial submissions from affiliates and functions. Support OpEx tracking across European legal entities and the regional office. Partner with Accounting and Global Finance teams during monthly close and reporting cycles. Assist with contract tracking, accruals, purchase orders, and budget monitoring activities. Support financial systems enhancements, reporting automation, and dashboard develop